Na+/Ca2+ exchange and Na+/K+-ATPase in the heart

Journal of Physiology

Volumn 593, Issue 6, 2015, Pages 1361-1382

  Shattock, Michael J ^a   Ottolia, Michela ^b   Bers, Donald M ^c   Blaustein, Mordecai P ^d   Boguslavskyi, Andrii ^a   Bossuyt, Julie ^c   Bridge, John H B ^e   Chen Izu, Ye ^c   Clancy, Colleen E ^c   Edwards, Andrew ^f,g   Goldhaber, Joshua ^b   Kaplan, Jack ^h   Lingrel, Jerry B ⁱ   Pavlovic, Davor ^a   Philipson, Kenneth ^j   Sipido, Karin R ^k   Xie, Zi Jian ^l  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g SIMULA RESEARCH LABORATORY   (Norway)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l MEDICAL COLLEGE OF OHIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; CARDIOTONIC STEROID; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; STEROID; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM BALANCE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL PH; CHRONIC KIDNEY DISEASE; CRYSTAL STRUCTURE; CYTOPLASM; DISEASE ASSOCIATION; ENERGY METABOLISM; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR SPACE; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HYDROLYSIS; METABOLIC REGULATION; MOLECULAR INTERACTION; MUSCLE FATIGUE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SODIUM BALANCE; SODIUM CALCIUM EXCHANGE; SODIUM TRANSPORT; STOICHIOMETRY; ACTION POTENTIAL; ANIMAL; CARDIAC MUSCLE CELL; HEART ARRHYTHMIA; METABOLISM; ORGANIZATION; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; CONGRESSES AS TOPIC; HUMANS; MYOCYTES, CARDIAC; SODIUM-CALCIUM EXCHANGER; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84924588019     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.282319     Document Type: Article

References (250)

1. Abarquez RF Jr (1967). Digitalis in the treatment of hypertension. A preliminary report. Acta Med Philipp 3, 161-170.
2. 2+ exchange currents. J Physiol 589, 2569-2583.
3. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr & Gheorghiade M (2006). Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114, 397-403.
4. 2-subunit isoforms. FEBS Lett 536, 198-202.
5. Allen DG, Lamb GD & Westerblad H (2008). Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 88, 287-332.
6. 2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells. J Biol Chem 286, 37919-37931.
7. Antoons G, Willems R & Sipido KR (2012). Alternative strategies in arrhythmia therapy: evaluation of Na/Ca exchange as an anti-arrhythmic target. Pharmacol Ther 134, 26-42.
8. Armoundas AA, Hobai IA, Tomaselli GF, Winslow RL & O'Rourke B (2003). Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 93, 46-53.
9. +. Am J Physiol Heart Circ Physiol 279, H679-H691.
10. 2+ ATPases. Proc Natl Acad Sci USA 98, 10061-10066.
11. Baecher S, Kroiss M, Fassnacht M & Vogeser M (2014). No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS. Clin Chim Acta 431, 87-92.
12. +-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31, 1097-1103.
13. Bagrov YY, Manusova NB, Egorova IA, Fedorova OV & Bagrov AY (2005). Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front Biosci 10, 2257-2262.
14. 2+ exchange inhibitor 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate (KB-R7943) also blocks ryanodine receptors type 1 (RyR1) and type 2 (RyR2) channels. Mol Pharmacol 76, 560-568.
15. Beevers AJ & Kukol A (2006). Secondary structure, orientation, and oligomerization of phospholemman, a cardiac transmembrane protein. Protein Sci 15, 1127-1132.
16. Benziane B, Widegren U, Pirkmajer S, Henriksson J, Stepto NK & Chibalin AV (2011). Effect of exercise and training on phospholemman phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301, E456-E466.
17. 2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res 73, 92-100.
18. Bers DM & Ginsburg KS (2007). Na:Ca stoichiometry and cytosolic Ca-dependent activation of NCX in intact cardiomyocytes. Ann NY Acad Sci 1099, 326-338.
19. 2+ exchanger is essential for regulation: Crystal structures and mutational analysis. Proc Natl Acad Sci USA 104, 18467-18472.
20. Best PJ, Reddan DN, Berger PB, Szczech LA, McCullough PA & Califf RM (2004). Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 148, 230-242.
21. Bibert S, Roy S, Schaer D, Horisberger JD & Geering K (2008). Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na, K-ATPase isozymes. J Biol Chem 283, 476-486.
22. Biesmans L, Macquaide N, Heinzel FR, Bito V, Smith GL & Sipido KR (2011). Subcellular heterogeneity of ryanodine receptor properties in ventricular myocytes with low T-tubule density. PloS One 6, e25100.
23. Blaustein MP (2014). 'Why isn't endogenous ouabain more widely accepted?' Am J Physiol Heart Circ Physiol 307, H635-H639.
24. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, Van Huysse JW, Zhang J & Wier WG (2012). How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 302, H1031-H1049.
25. Boguslavskyi A, Fuller W & Shattock MJ (2014a). Phospholemman-dependent regulation of Na/K-ATPase modulates constriction and relaxation in aortic smooth muscle. Biophys J 106, 725a.
26. Boguslavskyi A, Pavlovic D, Aughton K, Clark JE, Howie J, Fuller W & Shattock MJ (2014b). Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman. Cardiovasc Res 104, 72-82.
27. Bossuyt J, Ai X, Moorman JR, Pogwizd SM & Bers DM (2005). Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ Res 97, 558-565.
28. Bossuyt J, Despa S, Han F, Hou Z, Robia SL, Lingrel JB & Bers DM (2009). Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem 284, 26749-26757.
29. Bossuyt J, Despa S, Martin JL & Bers DM (2006). Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump. J Biol Chem 281, 32765-32773.
30. 2+ exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function. Circ Arrhythm Electrophysiol 6, 371-379.
31. + pump. Am J Physiol Cell Physiol 281, C1059-C1063.
32. + channels. Microcirculation 11, 279-293.
33. Casteels R, Kitamura K, Kuriyama H & Suzuki H (1977). The membrane properties of the smooth muscle cells of the rabbit main pulmonary artery. J Physiol 271, 41-61.
34. + pump regulation and skeletal muscle contractility. Physiol Rev 83, 1269-1324.
35. Clifford RJ & Kaplan JH (2008). β-Subunit overexpression alters the stoicheometry of assembled Na-K-ATPase subunits in MDCK cells. Am J Physiol Renal Physiol 295, F1314-F1323.
36. Clifford RJ & Kaplan JH (2009). Regulation of Na, K-ATPase subunit abundance by translational repression. J Biol Chem 284, 22905-22915.
37. + ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling. Circ Res 114, 249-256.
38. Crambert G, Fuzesi M, Garty H, Karlish S & Geering K (2002). Phospholemman (FXYD1) associates with Na, K-ATPase and regulates its transport properties. Proc Natl Acad Sci USA 99, 11476-11481.
39. +-ATPase isoform distribution in rat ventricular myocytes. Am J Physiol Cell Physiol 293, C321-C327.
40. + transport in the normal and failing heart - Remember the balance. J Mol Cell Cardiol 61, 2-10.
41. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia LG, Kutchai H, Tucker AL & Bers DM (2005). Phospholemman-phosphorylation mediates the β-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97, 252-259.
42. Despa S, Brette F, Orchard CH & Bers DM (2003). Na/Ca exchange and Na/K-ATPase function are equally concentrated in transverse tubules of rat ventricular myocytes. Biophys J 85, 3388-3396.
43. + pump rate in rat and rabbit ventricular myocytes. J Physiol 539, 133-143.
44. + concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 105, 2543-2548.
45. 2+ release in cardiac myocytes. Cardiovasc Res 95, 480-486.
46. +-ATPase in caveolae of pulmonary artery smooth muscle cells. Biochimie 94, 991-1000.
47. 2+ transient of failing human ventricular myocytes. Circ Res 84, 435-444.
48. Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM & Doris PA (2000). Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension 36, 442-448.
49. Dong XH, Komiyama Y, Nishimura N, Masuda M & Takahashi H (2004). Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells. Clin Exp Pharmacol Physiol 31, 276-283.
50. Donohoe P, McMahon AC, Walgama OV, Bertaso F, Dockrell ME, Cramp HA, Mullen AM, Shattock MJ, Hendry BM & James AF (2000). L-type calcium current of isolated rat cardiac myocytes in experimental uraemia. Nephrol Dial Transplant 15, 791-798.
51. Ca3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res 102, 1247-1255.
52. 2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288, H477-H485.
53. Dostanic I, Schultz Jel J, Lorenz JN & Lingrel JB (2004). The α1 isoform of Na, K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. J Biol Chem 279, 54053-54061.
54. Dostanic-Larson I, Van Huysse JW, Lorenz JN & Lingrel JB (2005). The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102, 15845-15850.
55. El-Armouche A, Wittkopper K, Fuller W, Howie J, Shattock MJ & Pavlovic D (2011). Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase. FASEB J 25, 4467-4475.
56. Esler M, Lambert E & Schlaich M (2010). Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol (1985) 109, 1996-1998.
57. Fedorova LV, Raju V, El-Okdi N, Shidyak A, Kennedy DJ, Vetteth S, Giovannucci DR, Bagrov AY, Fedorova OV, Shapiro JI & Malhotra D (2009). The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol 296, F922-F934.
58. 1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation 105, 1122-1127.
59. Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG & Bagrov AY (2007). Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 25, 1834-1844.
60. Ferrandi M, Molinari I, Barassi P, Minotti E, Bianchi G & Ferrari P (2004). Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 279, 33306-33314.
61. +- ATPase alterations in ouabain and adducin-dependent hypertension. AmJPhysiol Regul Integr Comp Physiol 290, R529-R535.
62. + pump regulation. Circ Res 105, 185-193.
63. 2+ exchange protein in mammalian cardiac myocytes: an immunofluorescence and immunocolloidal gold-labeling study. J Cell Biol 117, 337-345.
64. Franzin CM, Gong XM, Teriete P & Marassi FM (2007a). Structures of the FXYD regulatory proteins in lipid micelles and membranes. J Bioenerg Biomembr 39, 379-383.
65. Franzin CM, Gong XM, Thai K, Yu J & Marassi FM (2007b). NMR of membrane proteins in micelles and bilayers: the FXYD family proteins. Methods 41, 398-408.
66. Fuller W, Eaton P, Bell JR & Shattock MJ (2004). Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J 18, 197-199.
67. Fuller W, Howie J, McLatchie LM, Weber RJ, Hastie CJ, Burness K, Pavlovic D & Shattock MJ (2009). FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 296, C1346-C1355.
68. Gallice PM, Kovacic HN, Brunet PJ, Berland YF & Crevat AD (1998). A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects. Clin Chim Acta 273, 149-160.
69. + pump current in ventricular myocytes from guinea pig heart. Pflugers Arch 437, 643-651.
70. Gao J, Sun X, Potapova IA, Cohen IS, Mathias RT & Kim JH (2014). Autocrine A2 in the T-system of ventricular myocytes creates transmural gradients in ion transport: a mechanism to match contraction with load? Biophys J 106, 2364-2374.
71. 2+ exchanger current disables fight or flight sinoatrial node activity without affecting resting heart rate. Circ Res 112, 309-317.
72. 2+ from the regulatory two-domain tandem of NCX1. J Biol Chem 285, 28117-28125.
73. 2+-dependent activation and deactivation in intact myocytes. J Physiol 591, 2067-2086.
74. Goldhaber JI, Lamp ST, Walter DO, Garfinkel A, Fukumoto GH & Weiss JN (1999). Local regulation of the threshold for calcium sparks in rat ventricular myocytes: role of sodium-calcium exchange. J Physiol 520, 431-438.
75. Gonick HC, Ding Y, Vaziri ND, Bagrov AY & Fedorova OV (1998). Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens 20, 617-627.
76. Grandi E, Pasqualini FS & Bers DM (2010). A novel computational model of the human ventricular action potential and Ca transient. J Mol Cell Cardiol 48, 112-121.
77. Groenke S, Larson ED, Alber S, Zhang R, Lamp ST, Ren X, Nakano H, Jordan MC, Karagueuzian HS, Roos KP, Nakano A, Proenza C, Philipson KD & Goldhaber JI (2013). Complete atrial-specific knockout of sodium-calcium exchange eliminates sinoatrial node pacemaker activity. PloS One 8, e81633.
78. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol Heart Circ Physiol 266, H2146-H2151.
79. + pump current: role of protein and nonprotein sulfhydryl redox status. Am J Physiol Heart Circ Physiol 38, H297-H319.
80. +)ATPase associated with essential hypertension. Nature 300, 650-652.
81. + pump function in cardiac myocytes. Circ Res 99, 1376-1383.
82. Harrison SM, McCall E & Boyett MR (1992). The relationship between contraction and intracellular sodium in rat and guinea pig ventricular myocytes. J Physiol 449, 517-550.
83. Harwood S, Mullen AM, McMahon AC & Dawnay A (2001). Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension. Am J Hypertens 14, 1112-1115.
84. 2-isoforms of Na-K-ATPase play different roles in skeletal muscle contractility. AmJPhysiol Regul Integr Comp Physiol 281, R917-R925.
85. Heiny JA, Kravtsova VV, Mandel F, Radzyukevich TL, Benziane B, Prokofiev AV, Pedersen SE, Chibalin AV & Krivoi II (2010). The nicotinic acetylcholine receptor and the Na, K-ATPase α2 isoform interact to regulate membrane electrogenesis in skeletal muscle. J Biol Chem 285, 28614-28626.
86. +-ATPase: alpha 1-, alpha 2-, and beta 1-mRNA and -protein levels at steady state. Am J Physiol Cell Physiol 262, C484-C492.
87. Herrmann S, Lipp P, Wiesen K, Stieber J, Nguyen H, Kaiser E & Ludwig A (2013). The cardiac sodium-calcium exchanger NCX1 is a key player in the initiation and maintenance of a stable heart rhythm. Cardiovasc Res 99, 780-788.
88. 2+ sensors. Mol Cell 22, 15-25.
89. Hilgemann DW, Collins A & Matsuoka S (1992). Steady-state and dynamic properties of cardiac sodium-calcium exchange. Secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol 100, 933-961.
90. 2+ exchange activity in canine pacing-induced heart failure. Circ Res 87, 690-698.
91. Hobbs RE (1997). Digoxin's effect on mortality and hospitalization in heart failure: implications of the DIG study. Digitalis Investigation Group. Cleve Clin J Med 64, 234-237.
92. Horvat D, Severson J, Uddin MN, Mitchell B & Puschett JB (2010). Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy 29, 1-9.
93. + pump by palmitoylation of its catalytic and regulatory subunits. Biochem Soc Trans 41, 95-100.
94. Huang BS, Amin MS & Leenen FH (2006). The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 21, 295-304.
95. +] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 287, H1160-H1166.
96. Huang BS, Veerasingham SJ & Leenen FH (1998). Brain 'ouabain, ' ANG II, and sympathoexcitation by chronic central sodium loading in rats. Am J Physiol Heart Circ Physiol 274, H1269-H1276.
97. + in Dahl salt-sensitive vs. -resistant rats. Am J Physiol Heart Circ Physiol 281, H1881-H1889.
98. +-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267, 5040-5043.
99. 2+ exchanger. FEBS Lett 446, 264-268.
100. 2+ affinity. J Biol Chem 275, 38571-38580.
101. 2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets 7, 188-198.
102. James PF, Grupp IL, Grupp G, Woo AL, Askew GR, Croyle ML, Walsh RA & Lingrel JB (1999). Identification of a specific role for the Na, K-ATPase α2 isoform as a regulator of calcium in the heart. Mol Cell 3, 555-563.
103. Jayasinghe ID, Cannell MB & Soeller C (2009). Organization of ryanodine receptors, transverse tubules, and sodium-calcium exchanger in rat myocytes. Biophys J 97, 2664-2673.
104. 2+ exchanger has two cytoplasmic ion permeation pathways. Proc Natl Acad Sci USA 110, 7500-7505.
105. 2+ exchanger dimers. Proc Natl Acad Sci USA 108, 1699-1704.
106. Jorgensen PL, Hakansson KO & Karlish SJ (2003). Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu Rev Physiol 65, 817-849.
107. + in human skeletal muscle during and after dynamic graded exercise determined by microdialysis. Am J Physiol Regul Integr Comp Physiol 278, R400-R406.
108. + pump low and high ouabain affinity α subunit isoforms are differently distributed incells. Proc Natl Acad Sci USA 94, 1800-1805.
109. +-ATPase preceding the E1P state. Nature 502, 201-206.
110. Kaplan JH (2002). Biochemistry of Na, K-ATPase. Annu Rev Biochem 71, 511-535.
111. Karim CB, Zhang Z, Howard EC, Torgersen KD & Thomas DD (2006). Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J Mol Biol 358, 1032-1040.
112. Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi K, Gupta S, Tian J, Morgan E, Khouri S, Cooper CJ, Periyasamy SM, Xie Z, Malhotra D, Fedorova OV, Bagrov AY & Shapiro JI (2008). Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 294, F450-F454.
113. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY & Shapiro JI (2006). Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47, 488-495.
114. +-ATPase E960 and phospholemman F28 are critical for their functional interaction. Proc Natl Acad Sci USA 109, 20756-20761.
115. Kimura K, Manunta P, Hamilton BP & Hamlyn JM (2000). Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res 23 (Suppl.), S67-76.
116. + increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 121, 1606-1613.
117. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M & Takahashi H (2005). A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 38, 36-45.
118. 2+ transient: evidence from NCX knockout mice. J Physiol 588, 3267-3276.
119. Laredo J, Hamilton BP & Hamlyn JM (1995). Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun 212, 487-493.
120. +-ATPase differ in distinct subcellular membranes from rat skeletal muscle. Biochemistry 36, 7726-7732.
121. 2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Can J Cardiol 21, 509-516.
122. 2+ sensor. Proc Natl Acad Sci USA 103, 13232-13237.
123. Leung HS, Yung LM, Leung FP, Yao X, Chen ZY, Ko WH, Laher I & Huang Y (2006). Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms. Br J Pharmacol 149, 703-711.
124. Li C, Grosdidier A, Crambert G, Horisberger JD, Michielin O & Geering K (2004). Structural and functional interaction sites between Na, K-ATPase and FXYD proteins. J Biol Chem 279, 38895-38902.
125. Li S, Liu G, Jia J, Miao Y, Gu S, Miao P, Shi X, Wang Y & Yu C (2010). Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method. Clin Biochem 43, 307-313.
126. Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J & Xie ZJ (2007). Identification of a pool of non-pumping Na/K-ATPase. J Biol Chem 282, 10585-10593.
127. Liao J, Li H, Zeng W, Sauer DB, Belmares R & Jiang Y (2012). Structural insight into the ion-exchange mechanism of the sodium/calcium exchanger. Science 335, 686-690.
128. 2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance? Am J Physiol Heart Circ Physiol 303, H784-H794.
129. +-ATPase: α/β/FXYD subunit stoichiometry and cross-linking. J Biol Chem 281, 5947-5955.
130. Lingrel JB (2010). The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na, K-ATPase. Ann Rev Physiol 72, 395-412.
131. +-ATPase. J Biol Chem 269, 19659-19662.
132. Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z & Shapiro JI (2004). Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int 66, 227-241.
133. Liu J, Liang M, Liu L, Malhotra D, Xie Z & Shapiro JI (2005). Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int 67, 1844-1854.
134. Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D, Xie Z & Shapiro JI (2002). Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int 62, 2118-2125.
135. 2+ concentrations. J Biol Chem 275, 27838-27844.
136. Liu T, Brown DA & O'Rourke B (2010). Role of mitochondrial dysfunction in cardiac glycoside toxicity. J Mol Cell Cardiol 49, 728-736.
137. 2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 103, 279-288.
138. +-ATPase subunit. Am J Physiol Heart Circ Physiol 295, H273-H280.
139. 2+ release in human failing cardiomyocytes. Cardiovasc Res 62, 63-73.
140. 5 (related to ion channel). J Biol Chem 280, 37717-37724.
141. Lundmark JL, Ramasamy R, Vulliet PR & Schaefer S (1999). Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts. Am J Physiol Heart Circ Physiol 277, H999-H1006.
142. 2+ transport. Biochem J 406, 365-382.
143. McDonough AA, Zhang Y, Shin V & Frank JS (1996). Subcellular distribution of sodium pump isoform subunits in mammalian cardiac myocytes. Am J Physiol Cell Physiol 270, C1221-C1227.
144. McMahon AC, Greenwald SE, Dodd SM, Hurst MJ & Raine AE (2002). Prolonged calcium transients and myocardial remodelling in early experimental uraemia. Nephrol Dial Transplant 17, 759-764.
145. 2+ exchanger in single uremic cardiac myocytes. Kidney Int 69, 846-851.
146. McMahon AC, Vescovo G, Dalla Libera L, Wynne DG, Fluck RJ, Harding SE & Raine AE (1996). Contractile dysfunction of isolated ventricular myocytes in experimental uraemia. Exp Nephrol 4, 144-150.
147. Manunta P, Hamilton BP & Hamlyn JM (2006). Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 290, R553-R559.
148. Manunta P, Hamilton J, Rogowski AC, Hamilton BP & Hamlyn JM (2000). Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23 (Suppl), S77-85.
149. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, Hamlyn JM & Bianchi G (1999). Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 34, 450-456.
150. 2+-exchanger modulates intercellular communication. Circ Res 100, 1026-1035.
151. Matchkov VV, Moeller-Nielsen N, Dam VS, Nourian Z, Briggs Boedtkjer DM & Aalkjaer C (2012). The α2 isoform of the Na, K-pump is important for intercellular communication, agonist-induced contraction, and EDHF-like response in rat mesenteric arteries. Am J Physiol Heart Circ Physiol 303, H36-H46.
152. 2+ exchange current in guinea-pig ventricular myocytes. J Physiol 476, 443-458.
153. 2+-binding domain. J Gen Physiol 105, 403-420.
154. Medbo JI & Sejersted OM (1990). Plasma potassium changes with high intensity exercise. J Physiol 421, 105-122.
155. 3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 3, e423.
156. Molin JC, Sguilla FS & Bendhack LM (2005). Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium. Eur J Pharmacol 522, 94-99.
157. Morimoto S, Cassell MD, Beltz TG, Johnson AK, Davisson RL & Sigmund CD (2001). Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res 89, 365-372.
158. Morimoto S, Cassell MD & Sigmund CD (2002). Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem 277, 33235-33241.
159. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, Andersen JP, Vilsen B & Nissen P (2007). Crystal structure of the sodium-potassium pump. Nature 450, 1043-1049.
160. Murrell JR, Randall JD, Rosoff J, Zhao JL, Jensen RV, Gullans SR & Haupert GT Jr (2005). Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 112, 1301-1308.
161. Neco P, Rose B, Huynh N, Zhang R, Bridge JH, Philipson KD & Goldhaber JI (2010). Sodium-calcium exchange is essential for effective triggering of calcium release in mouse heart. Biophys J 99, 755-764.
162. 23Na-nuclear magnetic resonance study of the isolated rat heart. Circulation 86, 302-310.
163. 2+ exchanger. J Biol Chem 271, 13385-13391.
164. 2+ binding motif. J Biol Chem 281, 21577-21581.
165. + transport in the maintenance of contractility in rat skeletal muscle. Acta Physiol Scand 157, 199-209.
166. + homeostasis and excitability in contracting muscles: implications for fatigue. Appl Physiol Nutr Metab 32, 974-984.
167. 2+ exchange inhibitor in guinea pig cardiac ventricular myocytes. Eur J Pharmacol 573, 161-169.
168. +-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 106, 13742-13747.
169. 2+ exchanger. J Biol Chem 280, 1061-1069.
170. 2+ exchanger. J Biol Chem 284, 32735-32741.
171. 2+ load attributable to the predominance of forward mode block. Circ Res 102, 1398-1405.
172. Palmer CJ, Scott BT & Jones LR (1991). Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266, 11126-11130.
173. Pamnani MB, Chen S, Yuan CM & Haddy FJ (1994). Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension 23, I106-109.
174. Pavlovic D (2014). The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease. Nephron Clin Pract (in press); DOI: 10.1159/000363301.
175. Pavlovic D, Aksentijevic D, Seymour AL, Fuller W & Shattock MJ (2010). A soluble inhibitor depresses Na/K ATPase activity in cardiomyopathic hearts from uremic rats. Circulation 122, A16016.
176. Pavlovic D, Fuller W & Shattock MJ (2007). The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J 21, 1539-1546.
177. 2+ by modulating Na/K ATPase via PKCεand phospholemman-dependent mechanism. J Mol Cell Cardiol 61, 164-171.
178. 2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem 271, 10372-10378.
179. Periyasamy SM, Chen J, Cooney D, Carter P, Omran E, Tian J, Priyadarshi S, Bagrov A, Fedorova O, Malhotra D, Xie Z & Shapiro JI (2001). Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int 60, 2367-2376.
180. 2+ exchange molecule: an overview. Ann NY Acad Sci 976, 1-10.
181. Pierre SV & Xie Z (2006). The Na, K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 46, 303-316.
182. i and contractility in nonfailing and failing human myocardium. Circulation 106, 447-453.
183. Pogwizd SM (2003). Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents. Drugs 63, 439-452.
184. Pogwizd SM & Bers DM (2002). Na/Ca exchange in heart failure: contractile dysfunction and arrhythmogenesis. Ann NY Acad Sci 976, 454-465.
185. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85, 1009-1019.
186. Pogwizd SM, Sipido KR, Verdonck F & Bers DM (2003). Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res 57, 887-896.
187. 2+ flux. Circ Res 97, 1288-1295.
188. Price EM & Lingrel JB (1988). Structure-function relationships in the Na, K-ATPase αsubunit: site-directed mutagenesis of glutamine-111 to arginine and asparagine-122 to aspartic acid generates a ouabain-resistant enzyme. Biochemistry 27, 8400-8408.
189. 2+ clearance proteins in smooth muscle: a functional unit. Am J Physiol Heart Circ Physiol 299, H548-H556.
190. +-ATPase in smooth muscle decreases blood pressure. Am J Physiol Heart Circ Physiol 293, H1172-H1182.
191. 2+ exchanger-1 and TRPC/Orai-containing channels: key players in arterial hypertension. Adv Exp Med Biol 961, 365-374.
192. Pullen MA, Brooks DP & Edwards RM (2004). Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids. J Pharmacol Exp Ther 310, 319-325.
193. Quinn K, Guibert C & Beech DJ (2000). Sodium-potassium-ATPase electrogenicity in cerebral precapillary arterioles. Am J Physiol Heart Circ Physiol 279, H351-H360.
194. Radzyukevich TL, Lingrel JB & Heiny JA (2009). The cardiac glycoside binding site on the Na, K-ATPase α2 isoform plays a role in the dynamic regulation of active transport in skeletal muscle. Proc Natl Acad Sci USA 106, 2565-2570.
195. Radzyukevich TL, Neumann JC, Rindler TN, Oshiro N, Goldhamer DJ, Lingrel JB & Heiny JA (2013). Tissue-specific role of the Na, K-ATPase α2 isozyme in skeletal muscle. J Biol Chem 288, 1226-1237.
196. Rasmussen HH & Figtree G (2007). 'Don't flog the heart!' - development of specific drug therapies for heart failure. Crit Care Resusc 9, 364-369.
197. Reeves JP & Condrescu M (2003). Allosteric activation of sodium-calcium exchange activity by calcium: persistence at low calcium concentrations. J Gen Physiol 122, 621-639.
198. Rembold CM, Ripley ML, Meeks MK, Geddis LM, Kutchai HC, Marassi FM, Cheung JY & Moorman JR (2005). Serine 68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation. J Vasc Res 42, 483-491.
199. 2+ exchanger proteins: evidence for dimer formation. Biochemistry 47, 6081-6087.
200. 2+ exchanger, NCX1. J Mol Cell Cardiol 57, 68-71.
201. 2+ exchange inhibitors. Circ Res 91, 90-92.
202. 2-isoform in the cardiovascular system does not alter basal blood pressure but prevents ACTH-induced hypertension. Am J Physiol Heart Circ Physiol 301, H1396-H1404.
203. Sathishkumar K, Ross RG, Bawankule DU, Sardar KK, Prakash VR & Mishra SK (2005). Segmental heterogeneity in the mechanism of sodium nitroprusside-induced relaxation in ovine pulmonary artery. J Cardiovasc Pharmacol 45, 491-498.
204. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D & Bader M (1999). Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 96, 3975-3980.
205. Schoner W (2002). Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269, 2440-2448.
206. Schwarz EM & Benzer S (1997). Calx, a Na-Ca exchanger gene of Drosophila melanogaster. Proc Natl Acad Sci USA 94, 10249-10254.
207. Shah JR, Laredo J, Hamilton BP & Hamlyn JM (1999). Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 33, 373-377.
208. Shattock MJ (2009). Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease. Curr Opin Pharmacol 9, 160-166.
209. Shattock MJ & Bers DM (1989). Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol Cell Physiol 256, C813-C822.
210. + pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique. Inhibition of the pump by oxidant stress. Circ Res 72, 91-101.
211. 2-isoform specifically couples to contractility in vascular smooth muscle: evidence from gene-targeted neonatal mice. Am J Physiol Cell Physiol 286, C813-C820.
212. 2+ exchanger. Ann NY Acad Sci 976, 19-30.
213. Shinoda T, Ogawa H, Cornelius F & Toyoshima C (2009). Crystal structure of the sodium-potassium pump at 2.4 Å resolution. Nature 459, 446-450.
214. Silverman B, Fuller W, Eaton P, Deng J, Moorman JR, Cheung JY, James AF & Shattock MJ (2005). Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res 65, 93-103.
215. Sipido KR, Volders PG, Vos MA & Verdonck F (2002). Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res 53, 782-805.
216. 2+ release in ventricular myocytes. Biophys J 94, L54-56.
217. 2+ uptake and catecholamine release in bovine adrenal chromaffin cells. J Pharmacol Sci 102, 88-95.
218. Song H, Karashima E, Hamlyn JM & Blaustein MP (2014). Ouabain-digoxin antagonism in rat arteries and neurones. J Physiol 592, 941-969.
219. Song Q, Pallikkuth S, Bossuyt J, Bers DM & Robia SL (2011). Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase. J Biol Chem 286, 9120-9126.
220. Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G, Hamlyn JM, Malatino LS, Bianchi G & Zoccali C (2008). Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 263, 274-280.
221. 2+ exchanger in end-stage human heart failure. Circ Res 75, 443-453.
222. 2+-ATPase of the sarcoplasmic reticulum. Biochem J 356, 685-704.
223. +-ATPase isoforms in myocardium. Isoforms change in deoxycorticosterone acetate-salt hypertension. Circ Res 74, 669-678.
224. 2-isoform regulates cardiac contractility in rat cardiomyocytes. Cardiovasc Res 75, 109-117.
225. Tani M & Neely JR (1989). Role of intracellular Na in Ca overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 65, 1045-1056.
226. Taniguchi K, Kaya S, Abe K & Mardh S (2001). The oligomeric nature of Na/K-transport ATPase. J Biochem 129, 335-342.
227. Teriete P, Franzin CM, Choi J & Marassi FM (2007). Structure of the Na, K-ATPase regulatory protein FXYD1 in micelles. Biochemistry 46, 6774-6783.
228. + pump expression, phospholemman (FXYD1) phosphorylation, and performance in soccer players. J Appl Physiol (1985) 108, 898-905.
229. Thomassen M, Murphy RM & Bangsbo J (2013). Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans. J Physiol 591, 1523-1533.
230. Thomassen M, Rose AJ, Jensen TE, Maarbjerg SJ, Bune L, Leitges M, Richter EA, Bangsbo J & Nordsborg NB (2011). Protein kinase Cαactivity is important for contraction-induced FXYD1 phosphorylation in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 301, R1808-R1814.
231. Tian J, Haller S, Periyasamy S, Brewster P, Zhang H, Adlakha S, Fedorova OV, Xie ZJ, Bagrov AY, Shapiro JI & Cooper CJ (2010). Renal ischemia regulates marinobufagenin release in humans. Hypertension 56, 914-919.
232. + channels. J Physiol 588, 4249-4260.
233. +-ATPase: new light on the oldest ion pump. Structure 19, 1732-1738.
234. Trafford AW, Diaz ME, O'Neill SC & Eisner DA (1995). Comparison of subsarcolemmal and bulk calcium concentration during spontaneous calcium release in rat ventricular myocytes. J Physiol 488, 577-586.
235. Tyralla K & Amann K (2002). Cardiovascular changes in renal failure. Blood Purif 20, 462-465.
236. 2-isoform. Am J Physiol Heart Circ Physiol 301, H2147-H2153.
237. + transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol 35, 5-25.
238. + concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res 57, 1035-1043.
239. + transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol 35, 5-25.
240. +-ATPase. J Biol Chem 279, 17250-17259.
241. + pump current in guinea-pig ventricular myocytes. J Physiol 509, 117-128.
242. 2+] during the cardiac action potential. Circ Res 90, 182-189.
243. +-ATPases. Br J Pharmacol 136, 918-926.
244. + pump via PKC-dependent activation of NADPH oxidase. Am J Physiol Cell Physiol 296, C693-C700.
245. Williams MW, Resneck WG, Kaysser T, Ursitti JA, Birkenmeier CS, Barker JE & Bloch RJ (2001). Na, K-ATPase in skeletal muscle: two populations of β-spectrin control localization in the sarcolemma but not partitioning between the sarcolemma and the transverse tubules. J Cell Sci 114, 751-762.
246. 2+ exchanger reveal incremental conformational transitions. J Biol Chem 285, 2554-2561.
247. 2+ efflux and its pH regulation. Proc Natl Acad Sci USA 110, 11367-11372.
248. 2+ regulation and its alternative splicing modification. J Mol Biol 387, 104-112.
249. Wypijewski KJ, Howie J, Reilly L, Tulloch LB, Aughton KL, McLatchie LM, Shattock MJ, Calaghan SC & Fuller W (2013). A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle. J Biol Chem 288, 13808-13820.
250. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG & Blaustein MP (2005). Sodium pump α2 subunits control myogenic tone and blood pressure in mice. J Physiol 569, 243-256.